A comprehensive search was conducted in PubMed, Web of Science, and OpenAlex for literature published between December 1, 2022, and December 31, 2024. Studies were included if they explicitly ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
A registry-based digital strategy that identified untreated patients and invited them to a telephone consultation more than ...
Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Matching Software Market Size, Share & Trends Analysis Report by Deployment Mode (Web & Cloud-based, on-premise), End Use (Pharmaceutical ...
Forbes contributors publish independent expert analyses and insights. Tor Constantino is an ex-reporter, turned AI consultant & tech writer. The cost to create an innovative drug within the U.S.
Randomized controlled trials remain the most effective tool in the pharmaceutical industry’s evidence-generation toolkit. They are crucial for demonstrating novel drugs' safety and efficacy, assessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results